Rickettsia africae is a tick-borne bacteria known to cause African tick bite fever (ATBF). While the disease was first described more than 100 years ago, knowledge of transmission risk factors and disease burden remain poorly described. To better understand the burden of R. africae, this article reviewed and summarized the published literature related to ATBF epidemiology and clinical management. Using a systematic approach, consistent with the PRISMA guidelines, we identified more than 100 eligible articles, including 65 epidemiological studies and 41 case reports. Most reports described R. africae in ticks and livestock, while human studies were less common. Human disease case reports were exclusively among returning travellers from non-endemic areas, which limits our disease knowledge among at-risk populations: people living in endemic regions. Substantial efforts to elucidate the ATBF risk factors and clinical manifestations among local populations are needed to develop effective preventative strategies and facilitate appropriate and timely diagnosis.

African tick bite fever (ATBF) is one of the most important rickettsial infections in international travellers to sub-Saharan Africa. The heterogeneity of Rickettsia africae infection rates among tick vector species has been studied. However, this information has not been systematised to allow for comparative estimates. Quantifying the trends and heterogeneity in R. africae infection rates among the different tick vector species is paramount in understanding the role in transmission to humans. A systematic search was conducted in PubMed, Web of Knowledge, Google Scholar, and SCOPUS from 2005 to 2020. The selection criteria included all studies in sub-Saharan Africa reporting R. africae infection rates in tick adults, nymphs, and larvae. A quality effects model was used in the meta-analysis due to the observed heterogeneity with an assessment of publication bias using funnel plots. The prevalence estimates were conducted by geographic region and tick genus from 32 studies reporting R. africae infection rates in ticks from sub-Saharan Africa. A total of 12,301 ticks comprising of adults (96.19%, n=11, 832), nymphs (3.6%, n=443) and larvae (0.2%, n=26) and 1214 pooled samples were evaluated for R. africae infection. The overall prevalence of R. africae was higher in Amblyomma spp. (48%, 95% CI: 26-70%) compared to Rhipicephalus spp. (1%, 95% CI: 0-5%), Hyalomma spp. (1%, 95% CI: 0-3%) and other tick genera (1%, 95% CI: 0-4%) throughout all regions. The highest prevalence in Amblyomma spp. was recorded in western Africa (53%, 95% CI: 14-90%) and in Rhipicephalus spp. in southern Africa (2%, 95% CI: 0-5%). Cattle were the most frequently sampled hosts across all tick vectors (62.98%, n=5492), followed by goats (19.07%, n= 1663) and sheep (9.1%, n= 793). To our knowledge, this is the first systematic and quantitative analysis of R. africae infection in tick vectors collected from mammalian hosts in sub-Saharan Africa. The results highlight a marked heterogeneity between species in different regions of sub-Saharan Africa and provide initial estimates of infection rates.

African tick bite fever (ATBF) is an acute febrile illness caused by Rickettsia africae. ATBF is an important differential diagnosis of acute febrile illness among returned travelers. However, little information is available on ATBF cases imported to Japan, as only seven have been reported to date. To characterize the epidemiological and clinical profiles of patients diagnosed with ATBF in Japan, we reported three new ATBF cases at our hospital between May 2015 and April 2018 and conducted a literature review.